Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Ganciclovir - Generic Drug Details

« Back to Dashboard

What are the generic sources for ganciclovir and what is the scope of ganciclovir freedom to operate?

is the generic ingredient in five branded drugs marketed by Bausch And Lomb, Exela Pharma Scs Llc, Ranbaxy Labs Ltd, Roche Palo, West-ward Pharms Int, Luitpold Pharms Inc, Par Sterile Products, and Fresenius Kabi Usa, and is included in ten NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for ganciclovir. Three suppliers are listed for this compound.

Summary for Generic Name: ganciclovir

Drug Master File Entries: see list24
Suppliers / Packagers: see list3
Bulk Api Vendors: see list89
Clinical Trials: see list25
Patent Applications: see list6,406
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ganciclovir at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
ganciclovir sodium
INJECTABLE;INJECTION076222-001Jul 16, 2003DISCNNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
CAPSULE;ORAL076457-002Jun 27, 2003DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
IMPLANT;IMPLANTATION020569-001Mar 4, 1996DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
GEL;OPHTHALMIC022211-001Sep 15, 2009RXYesYes► Subscribe► Subscribe
Roche Palo
CAPSULE;ORAL020460-001Dec 22, 1994DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus